Physician profile
Mindy Markowitz
NPI 1700034485
$2,458.24
in general payments reported to CMS, 2019-2025
36 companies · $420 in 2025
The $420 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.98 · 2022: $196 · 2023: $1,044 · 2024: $703 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,167.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $355.57 | 2022-2025 | Aurora Ev-Icd Mri Surescan, Micra, Minimed 780g |
| Boston Scientific Corporation | $285.30 | 2023-2024 | Accolade Sr, Resonate El Icd Vr |
| Terumo Medical Corporation | $191.01 | 2023 | Metacross Otw, Heartrail, Glidewire |
| Impulse Dynamics (USA) INC. | $163.85 | 2024 | Optimizer |
| Abbott Laboratories | $152.72 | 2023 | Mitraclip |
| Amgen INC. | $137.98 | 2022-2025 | Prolia, Evenity, Repatha |
| Heartflow, INC. | $136.99 | 2024 | |
| Merck Sharp & Dohme LLC | $99.87 | 2023-2025 | Verquvo, Lagevrio, Dificid |
| Stereotaxis INC | $94.98 | 2019 | |
| Janssen Biotech, INC. | $90.97 | 2022-2025 | Tremfya, Stelara, Remicade |
| Incyte Corporation | $63.95 | 2024-2025 | Jakafi |
| Lilly USA, LLC | $61.20 | 2023 | Taltz, Mounjaro |
| Ucb, INC. | $54.34 | 2022-2023 | Cimzia |
| Pfizer INC. | $50.08 | 2023-2025 | |
| Mallinckrodt Hospital Products INC. | $45.55 | 2022-2023 | Acthar |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mindy Markowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.